HCmed Innovations Co., Ltd., in collaboration with one of the world's top 10 pharmaceutical companies, has officially launched its vibrating mesh nebulizer, DeeproTM, in the Federative Republic of Brazil. The lauching took place this month (May 2019), making Brazil the first emerging market to count with the OTC product.
DeeproTM, marketed in Brazil as inAResp, has entered the Latin American market bringing a top-quality vibrating mesh nebulizer. Its cutting-edge technology allows to aerosolize medications, ensuring small particle size that can be inhaled deeply into the lungs.
HCmed is determined to continue working with top pharmaceutical companies around the world to deliver the benefits of its mesh nebulizers to different markets, bringing high-quality inhalation therapy to all patients.